The Krystyna Lesiak
Endowment Fund for the
Professional Development of
Graduate and Post-Graduate
Students of Polish Heritage†
The Krystyna Lesiak Endowment Fund for the Professional Development of Graduate and Post-Graduate Students of Polish Heritage (hereinafter referred to as the “Krystyna Lesiak Fund”).
Statement of Purpose of the Krystyna Lesiak Fund
Recognizing the crucial importance of the professional development of promising graduate and post-graduate students of Polish heritage from Poland or the United States, Dr. Kyoichi A. Watanabe, in memory of his beloved late wife, Krystyna Lesiak, by this document establishes an Endowment Fund within the Polish American Health Association, Inc. (hereinafter referred to as “PAHA”), the proceeds of which will be used for the professional development of promising graduate and post-graduate students in Poland or the United States of America, in chemical sciences related to medical research including but not limited to the areas of drug discovery (design and synthesis—organic, bioorganic, and medicinal chemistry) and development (biochemistry, pharmacology and toxicology). The aforegoing purposes may be amended in the future by the joint agreement of PAHA and Dr. Kyoichi Watanabe.
This endowment will fund awards supporting graduate and post-graduate student research presentations at national or international scientific meetings. Depending on the financial request and available endowment funds, the award will cover fully or partially the payment of registration fees, travel and accommodation costs, and other expenses related to presenting scientific findings relating to the above Statement of Purpose. The aforegoing objectives constitute the rightful activities for which the Krystyna Lesiak Fund has been created.
The Krystyna Lesiak Fund will award four-five or more awards per year depending on funds available for the awards this year.
Eligibility for Awards
To be eligible for The Krystyna Lesiak Fund (KLF) Travel Grant program, the potential award recipient
- A Polish citizen or of Polish descent.
- Admitted to a graduate or post-graduate program in Poland or the United States of America, in chemical sciences related to medical research or chemical biology including but not limited to the areas of drug discovery (design, synthesis, bioorganic, medicinal chemistry) and development (biochemistry, pharmacology, toxicology).
- Not more than 5 years after receiving the doctorate, except for special circumstances. The Nominating Committee will give the first priority for approval to the young graduate and post-graduate students however a limited amount of funds is available to award to more experienced scientists under special circumstances. To be eligible an appropriate justification must be provided.
- Presenting a scientific work in a conference either in the form of a poster or an oral presentation, or has been invited to visit American scientific institutions to establish research collaboration.
All award applications will be reviewed by a Nomination Committee. The most meritorious candidates will be selected by the Nomination Committee for the award.
Public Relations Activities
Winners must publicly acknowledge (at the scientific meeting and also in a perspective scientific publication) that they have received a Dr. Krystyna Lesiak Endowment Fund award.
† – abridged version of The Dr. Krystyna Lesiak Endowment Fund Agreement.